Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brunangelo Falini

Showing results (151-160 of 246) with videos related to

Pageof 25
Sort By:
Blood|December 7, 2014
BRAF inhibitors reverse the unique molecular signature and phenotype of hairy cell leukemia and exert potent antileukemic activityValentina Pettirossi, Alessia Santi, Elisa Imperi, et al.
Leukemia|March 18, 2021
Safety and efficacy of the BRAF inhibitor dabrafenib in relapsed or refractory hairy cell leukemia: a pilot phase-2 clinical trialEnrico Tiacci, Luca De Carolis, Edoardo Simonetti, et al.
American Journal of Hematology|August 19, 2024
Starry sky pattern predicts RAS pathway activation in NPM1-mutated acute myeloid leukemiaAlessandra Venanzi, Valeria Cardinali, Vincenzo Perriello, et al.
Cancers|February 2, 2021
CD123 Is Consistently Expressed on <i>NPM1</i>-Mutated AML CellsVincenzo Maria Perriello, Ilaria Gionfriddo, Roberta Rossi, et al.
Best Practice & Research. Clinical Haematology|September 20, 2011
Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantationMauro Di Ianni, Franca Falzetti, Alessandra Carotti, et al.
The Lancet. Oncology|July 1, 2021
Richter's transformation in the heartAndrea Marra, Francesco Adamo, Stefano Baldoni, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 17, 2012
T regulatory cell separation for clinical applicationMauro Di Ianni, Beatrice Del Papa, Tiziana Zei, et al.
Blood|March 22, 2015
Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cellsMaria Paola Martelli, Ilaria Gionfriddo, Federica Mezzasoma, et al.
Leukemia|February 14, 2019
GATA1 epigenetic deregulation contributes to the development of AML with NPM1 and FLT3-ITD cooperating mutationsPaolo Sportoletti, Letizia Celani, Emanuela Varasano, et al.
The New England Journal of Medicine|April 11, 2025
Targetable Mutations in <i>BRAF</i> V600E-Negative Hairy-Cell LeukemiaAlessia Santi, Alessandra Venanzi, Alessandra Pucciarini, et al.
Pageof 25

Showing results (151-160 of 246) with videos related to

Sort By:
Pageof 25
Blood|December 7, 2014
BRAF inhibitors reverse the unique molecular signature and phenotype of hairy cell leukemia and exert potent antileukemic activityValentina Pettirossi, Alessia Santi, Elisa Imperi, et al.
Leukemia|March 18, 2021
Safety and efficacy of the BRAF inhibitor dabrafenib in relapsed or refractory hairy cell leukemia: a pilot phase-2 clinical trialEnrico Tiacci, Luca De Carolis, Edoardo Simonetti, et al.
American Journal of Hematology|August 19, 2024
Starry sky pattern predicts RAS pathway activation in NPM1-mutated acute myeloid leukemiaAlessandra Venanzi, Valeria Cardinali, Vincenzo Perriello, et al.
Cancers|February 2, 2021
CD123 Is Consistently Expressed on <i>NPM1</i>-Mutated AML CellsVincenzo Maria Perriello, Ilaria Gionfriddo, Roberta Rossi, et al.
Best Practice & Research. Clinical Haematology|September 20, 2011
Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantationMauro Di Ianni, Franca Falzetti, Alessandra Carotti, et al.
The Lancet. Oncology|July 1, 2021
Richter's transformation in the heartAndrea Marra, Francesco Adamo, Stefano Baldoni, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 17, 2012
T regulatory cell separation for clinical applicationMauro Di Ianni, Beatrice Del Papa, Tiziana Zei, et al.
Blood|March 22, 2015
Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cellsMaria Paola Martelli, Ilaria Gionfriddo, Federica Mezzasoma, et al.
Leukemia|February 14, 2019
GATA1 epigenetic deregulation contributes to the development of AML with NPM1 and FLT3-ITD cooperating mutationsPaolo Sportoletti, Letizia Celani, Emanuela Varasano, et al.
The New England Journal of Medicine|April 11, 2025
Targetable Mutations in <i>BRAF</i> V600E-Negative Hairy-Cell LeukemiaAlessia Santi, Alessandra Venanzi, Alessandra Pucciarini, et al.
Pageof 25